Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 3 of 18
MIND Foods and Aerobic Training in Black Adults With HTN
NCT06152614
Digital Detection of Dementia (D Cubed) Studies: D3
NCT06224205
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
NCT06250309
Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
NCT05898074
Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK
NCT05789173
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals
NCT06099197
Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients
NCT05874843
A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease
NCT05733832
Registering Genomics and Imaging of Tumors (ReGIT)
NCT05386043
A Nasal Treatment for COVID-19
NCT05799521
Preoperative Corticosteroids in Autoimmune Thyroid Disease
NCT05435547
Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure
NCT05822141
Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen
NCT05821309
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
NCT05643144
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
NCT05733520
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
NCT07288827
Exercise in Metastatic Breast Cancer: EMBody
NCT05468034
Delivering Food Resources & Kitchen Skills (FoRKS) to Adults With Food Insecurity and Hypertension
NCT05856591
Obstacle Negotiation in Older People With and Without Vision Impairment
NCT05888441
Enhancing Prospective Thinking in Early Recovery
NCT05835921
Ketone Ester and Salt (KEAS) in Young Adults
NCT05545501
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
NCT05603702
Variable Intensive Early Walking Post-Stroke - 2 (VIEWS-2)
NCT05727930
Leg Heat Therapy in Peripheral Artery Disease
NCT05465070
Deep Brain Stimulation for Laryngeal Dystonia: From Mechanism to Optimal Application
NCT05506085
Prospective Validation of a Points Score System Predicting 30-day Survival
NCT05100342
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
NCT05346796
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
NCT05889546
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NCT05508165
The Periviable GOALS Decision Support Tool
NCT05264779
Factors Affecting Sensory and Motor Learning
NCT05374460
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
NCT05124808
Robotic Gait Rehabilitation in Parkinson's Disease
NCT05218187
Biomarker of Diabetic Retinopathy
NCT05079399
Daily Hand-Held Vibration Therapy
NCT04207437
Neural Basis of Sensory Learning: Brain Regions
NCT05079516
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT05108090
Locomotor Recovery and Compensation Post-stroke (LRC)
NCT05081713
5HTP Regulation Of Asthma In Children
NCT04160910
Molecular Mechanisms Associated With Breast Implant Complications
NCT05736354
The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients
NCT04700657
SAMe Trial for Patients With Alcoholic Cirrhosis
NCT04250259
Effects of Kinesio Tape on Delayed Onset Muscle Soreness
NCT04128670
Sex Differences in the Response to Abstinence From Alcohol.
NCT03827460
Gastric Per-Oral Endoscopic Myotomy (G-POEM) for the Treatment of Gastroparesis
NCT04434781
The Indiana Myeloma Registry
NCT03616483
Longitudinal Early-onset Alzheimer's Disease Study Protocol
NCT03507257
Endoscopic Ultrasound-Guided Celiac Plexus Neurolysis (EUS-CPN) for Chronic Pancreatitis
NCT04403074
Esophageal Impedance and Manometry Measurements and Dysphagia Symptom Scoring
NCT04503785
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
NCT05393661
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.